적소두가 비알코올성 지방간 질환 세포 모델에 미치는 효과

키워드

참고문헌 (36)

1. Chuthan Sourianarayanane A, "Management of non-alcoholic fatty liver disease", Minerva Gastroenterol Dietol, 59(1), pp.69~87 (2013)
2. Masuoka, H. C., "Nonalcoholic fatty liver disease : an emerging threat to obese and diabetic individuals", Ann N Y Acad Sci, 1281, pp.106~122 (2013)
3. Falck-Ytter, Y., "Clinical features and natural history of nonalcoholic steatosis syndromes", Semin Liver Dis, 21(1), pp.17~26 (2001)
4. Daniel, S., "Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients", Am J Gastroenterol, 94(10), pp.3010~3014 (1999)
5. Bugianesi, E., "Expanding the natural history of nonalcoholic steatohepatitis : from cryptogenic cirrhosis to hepatocellular carcinoma", Gastroenterology, 123(1), pp.134~140 (2002)
6. Ibrahim, M. A., "Nonalcoholic fatty liver disease : current and potential therapies", Life Sci, 92(2), pp.114~118 (2013)
7. Wu, J.N., "An illustrated Chinese materia", pp.474~ (2005), Oxford University Press
8. 허준, "동의보감", pp.745~ (1999), 법인문화사
9. Yao, Y., "Influence of altitudinal variation on the antioxidant and antidiabetic potential of azuki bean(Vigna angularis)", Int J Food Sci Nutr, 63(1), pp.117~124 (2012)
10. Yu, T., "Anti-inflammatory activity of ethanol extract derived from Phaseolus angularis beans", J Ethnopharmacol, 137(3), pp.1197~1206 (2011)
11. Nakaya, K., "Stimulation of dendritic cell maturation and induction of apoptosis in leukemia cells by a heat-stable extract from azuki bean(Vigna angularis), a promising immunopotentiating food and dietary supplement for cancer prevention", Asian Pac J Cancer Prev, 13(2), pp.607~611 (2012)
12. Hori, Y., "Antibacterial activity of plant extracts from azuki beans(Vigna angularis)in vitro", Phytother Res, 20(2), pp.162~164 (2006)
13. Itoh, T., "Hypoglycemic effect of hot-water extract of adzuki(Vigna angularis)in spontaneously diabetic KK-A(y)mice", Nutrition, 25(2), pp.134~141 (2009)
14. Mukai, Y., "Polyphenol-containing azuki bean(Vigna angularis)extract attenuates blood pressure elevation and modulates nitric oxide synthase and caveolin-1 expressions in rats with hypertension", Nutr Metab Cardiovasc Dis, 19(7), pp.491~497 (2009)
15. Itoh, T., "Lowering serum cholesterol level by feeding a 40% ethanol-eluted fraction from HP-20 resin treated with hot water extract of adzuki beans(Vigna angularis)to rats fed a high-fat cholesterol diet", Nutrition, 25(3), pp.318~321 (2009)
16. Liu, J., "An in vitro hepatic steatosis cell model for study of non-alcoholic fatty liver disease", Zhejiang Da Xue Xue Bao Yi Xue Ban, 38(6), pp.626~629 (2009)
17. Kim, D. S., "Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells", Immunopharmacol Immunotoxicol, 32(2), pp.251~257 (2010)
18. Cao, J., "Saturated fatty acid induction of endoplasmic reticulum stress and apoptosis in human liver cells via the PERK", ATF4, Mol Cell Biochem, pp.2012, 364(1-2)[DOI]
19. Browning, J. D., "Molecular mediators of hepatic steatosis and liver injury", J Clin Invest, 114(2), pp.147~152 (2004)
20. Pettinelli, P., "Molecular mechanisms of steatosis in nonalcoholic fatty liver disease", Nutr Hosp, 26(3), pp.441~450 (2011)
21. Repa, J. J., "Regulation of mouse sterol regulatory element-binding protein-1c gene(SREBP-1c)by oxysterol receptors, LXRalpha and LXRbeta", Genes Dev, 14(22), pp.2819~2830 (2000)
22. Viollet, B., "Activation of AMP-activated protein kinase in the liver : a new strategy for the management of metabolic hepatic disorders", J Physiol, 574(1), pp.41~53 (2006)
23. Kohjima, M., "SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease", Int J Mol Med, 21(4), pp.507~511 (2008)
24. Zhang, Y., "Liver LXRalpha expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice", J Clin Invest, 122(5), pp.1688~1699 (2012)
25. Zhou, G., "Role of AMP-activated protein kinase in mechanism of metformin action", J Clin Invest, 108(8), pp.1167~1174 (2001)
26. Lin, H. Z., "Metformin reverses fatty liver disease in obese, leptin-deficient mice", Nat Med, 6(9), pp.998~1003 (2000)
27. Shi, K. Q., "Traditional Chinese medicines benefit to nonalcoholic fatty liver disease : a systematic review and meta-analysis", Mol Biol Rep, 39(10), pp.9715~9722 (2012)
28. Laffitte, B. A., "Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue", Proc Natl Acad Sci U S A, 100(9), pp.5419~5424 (2003)
29. 이은경, "핵수용체의 대사 조절", Endocrinology and Metabolism, 23(3), pp.155~164 (2008), 대한내분비학회
30. Long, Y. C., "AMP-activated protein kinase signaling in metabolic regulation", J Clin Invest, 116(7), pp.1776~1783 (2006)
31. Ha, S. K., "Role of AMP-activated protein kinase and adiponectin during development of hepatic steatosis in high-fat diet-induced obesity in rats", J Comp Pathol, 145(1), pp.88~94 (2011)
32. Foretz, M., "Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver", Diabetes, 54(5), pp.1331~1339 (2005)
33. Kawaguchi, T., "Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase", J Biol Chem, 277(6), pp.3829~3835 (2002)
34. Munday, M. R., "Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase", Eur J Biochem, 175(2), pp.331~338 (1988)
35. Muoio, D.M., "AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target", Biochem J, 338(3), pp.783~791 (1999)
36. Clarke, P. R., "Regulation of HMG-CoA reductase : identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver", EMBO J, 9(8), pp.2439~2446 (1990)

관련 논문AI추천